Jasper Therapeutics (JSPR) Assets (2019 - 2025)

Jasper Therapeutics' Assets history runs 7 years deep, the most recent figure standing at $35.8 million for Q4 2025.

• In Q4 2025, Assets fell 55.22% year-over-year to $35.8 million; the TTM figure through Dec 2025 stood at $35.8 million (down 55.22% YoY), while the FY2025 annual figure was $35.8 million, down 55.22% from the prior year.
• Assets for Q4 2025 stood at $35.8 million, down from $57.5 million in the prior quarter.
• The five-year high for Assets was $138.8 million in Q1 2023, with the low at $35.8 million in Q4 2025.
• The 5-year median for Assets is $94.3 million (2021), against an average of $87.3 million.
• The sharpest annual moves came in 2021 and 2025: Assets surged 300.97% in 2021, then slumped 59.21% in 2025.
• Jasper Therapeutics' Assets stood at $93.7 million in 2021, then tumbled by 48.36% to $48.4 million in 2022, then soared by 96.22% to $94.9 million in 2023, then dropped by 15.8% to $79.9 million in 2024, then slumped by 55.22% to $35.8 million in 2025.
• Business Quant data shows JSPR's Assets at $35.8 million in Q4 2025, $57.5 million in Q3 2025, and $46.5 million in Q2 2025.